Table 2.
A |
B |
|||
---|---|---|---|---|
Age groups | n | Aa, n(%) | n | Aa, n(%) |
YP | 934 | 379 (40.6) | 337 | 162 (48.1) |
OP | 2,535 | 529 (20.9) | 1,108 | 273 (24.6) |
YP + OP | 3,459 | 908 (26.3) | 1,445 | 435 (30.1) |
Aa was significantly more prevalent among YP than among OP (A, B; p < 0.001).
A, distribution of Aa-positive samples; B, distribution of Aa-positive patients.